First U.S. surgeries have been performed with Silony Medical's VERTICALE posterior double rod fixation system, used for stabilizing the thoracic and lumbar spine.
Zimmer Biomet received an FDA Warning Letter related to observed non-conformities with current good manufacturing practice requirements at the company's North Campus facility in Warsaw, Indiana.
Centinel Spine completed initial cases with three different implant portfolios within its FLX platform of Integrated Interbody and non-integrated 3D-printed interbody fusion devices.
The 21 companies we track collectively grew +3.6% in 1H18 vs. 1H17, still on pace to reach our estimates of +3.7% in orthopaedic industry growth for 2018 vs. 2017.
To measure and improve patient care, NASS has launched a diagnosis-based clinical data registry to track outcomes. The web-based platform will allow healthcare providers to collect and analyze their spine care data and compare it to the de-identified data in the entire registry.
With 1H18 spine revenue growth reporting all over the board, and still without concrete consensus from companies and analysts on the state and future of the segment, I got really curious about M&A transactions in the space. What have companies done to purchase what they needed or divest what wasn't working?